Complementary and Alternative Medicine Career Transition Award (K22)

The summary for the Complementary and Alternative Medicine Career Transition Award (K22) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Complementary and Alternative Medicine Career Transition Award (K22): - The goal of this funding opportunity is to provide support for outstanding advanced postdoctoral research scientists during their transition to independence. The award will provide support for up to 1 year of postdoctoral research training, and 3 years of research support as an independent investigator. This award is limited to postdoctoral trainees who propose research in complementary and alternative medicine (CAM) for the independent investigator phase of this award. - Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. - This program announcement uses the NIH Research Scholar Development Award (K22) mechanism. Eligible organizations include: - For-profit organizations, - Non-profit organizations, - Public or private institutions, such as universities, colleges, hospitals, and laboratories - Eligible agencies of the Federal government, including the NIH intramural program, are eligible for the postdoctoral phase of this award only, - Foreign institutions are not eligible for this award. Eligible Principal Investigators include scientists with clinical or research doctorates (including Ph.D., M.D., D.O. D.C., N.D., D.D.S., D.V.M., Sc.D., D.N.S. or equivalent doctoral degrees) who have at least 1 year but no more than 5 years of postdoctoral research training. In addition, applicants must also be currently - supported by an NCCAM Institutional NRSA training grant (T32) OR - supported by an NCCAM Individual NRSA postdoctoral fellowship award (F32); OR - supported by a T32 or F32 grant from another NIH Institute or Center; OR - supported on an Intramural Research Training Award Fellowship, such as an IRTA. - Individuals supported by other prestigious national or international individual postdoctoral awards will also be considered. - Applicants may submit only one K22 application, and may not simultaneously submit applications for other career awards (K-series mechanisms). Applicants are permitted to submit revised K22 applications. - Grantees will be expected to devote 100 percent of their time during the postdoctoral phase and a minimum of 75 percent of their time in the independent phase to the proposed research. - See Section IV for application materials - Telecommunications for the hearing impaired is available at: TTY 301-451-0088
Federal Grant Title: Complementary and Alternative Medicine Career Transition Award (K22)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-05-129
Type of Funding: Grant
CFDA Numbers: 93.213
CFDA Descriptions: Research and Training in Complementary and Alternative Medicine
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Jun 23, 2005
Creation Date: Jun 23, 2005
Archive Date: Oct 02, 2008
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Eligible agencies of the Federal Government are eligible to apply. The applicant institution should be the postdoctoral phase institution. All institutions types listed above are eligible for both the postdoctoral and independent phase, with one exception: Eligible agencies of the Federal government, such as the NIH intramural program, are eligible for the postdoctoral phase only. Foreign institutions are not eligible to apply for this grant.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
Similar Government Grants
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials o...
Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (Collaborati...
Methods Development in Natural Products Chemistry (R43/R44 Clinical Trial Not Allowed)
Methods Development in Natural Products Chemistry (R41/R42 Clinical Trial Not Allowed)
Discovery and Biological Signatures of Diet Derived Microbial Metabolites (R01 Clinical Tr...
Probiotics for Pediatric Illnesses
Cam Practitioner Research Education Project Grant Partnership
Centers of Excellence for Research on Complementary and Alternative Medicine (CERC) [P01]
More Grants from the National Institutes of Health
Development of New Technologies and Bioengineering Solutions for the Advancement of Cell R...
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical ...
Development and Integration of Novel Components for Open and Closed Loop Hormone Replaceme...
Exploiting Omics Assays to Investigate Molecular Regulation of Persistent HIV in Individua...
Elucidating the Effect of Glycemic Excursions on Patient Well-being and Cognitive Status i... is not endorsed by, or affiliated with, any government agency. Copyright ©2018